Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
Breviscapine (BVP), a flavonoid compound, is widely used in the treatment of cardiovascular and cerebrovascular diseases; however, the low oral bioavailability and short half-life properties limit its application. The aim of this study was to investigate the three preparations for improving its oral...
Saved in:
Main Authors: | Zilin Song (Author), Jiaojiao Yin (Author), Peifu Xiao (Author), Jin Chen (Author), Jingxin Gou (Author), Yanjiao Wang (Author), Yu Zhang (Author), Tian Yin (Author), Xing Tang (Author), Haibing He (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder
by: Ting Zhang, et al.
Published: (2022) -
Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
by: Haowen Li, et al.
Published: (2021) -
Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents
by: Kattamanchi Gnananath, et al.
Published: (2017) -
Glucocorticoids-based prodrug design: Current strategies and research progress
by: Hongbing Liu, et al.
Published: (2024) -
Preparation and in vivo evaluation of an intravenous emulsion loaded with an aprepitant-phospholipid complex
by: Yan Li, et al.
Published: (2023)